Generation of anti-human TIM-3 monoclonal antibody for cancer immunotherapy.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e15135
Abstract: e15135Background: Many clinical trials show that immunotherapy become one of effective strategy in cancer treatment. The benefits of PD-1 and CTLA-4 have revealed the huge success in different type... read more here.
Keywords: generation anti; tim monoclonal; anti human; cancer ... See more keywords